Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
about
The latent transforming growth factor beta binding protein (LTBP) familyFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerFuture possibilities in the prevention of breast cancer: breast cancer prevention trials.Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast GroupTamoxifen and risk of idiopathic venous thromboembolismIncreased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production.Phyto-oestrogens: a potential role in the prevention of CHD?Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection.Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment.Adjuvant tamoxifen: how long before we know how long?Meta-analysis of vascular and neoplastic events associated with tamoxifenPotential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors.Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen.Tamoxifen in axillary node--negative breast cancer: multisystem benefits and risks.Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variantsManagement of early breast cancer.Long term effects of tamoxifen on blood lipid values in breast cancer.The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.Tamoxifen dilates porcine coronary arteries: roles for nitric oxide and ouabain-sensitive mechanismsLetrozole as adjuvant endocrine therapy in postmenopausal women with breast cancer.Nanotamoxifen Delivery System: Toxicity Assessment After Oral Administration and Biodistribution Study After Intravenous Delivery of Radiolabeled Nanotamoxifen.Myocardial infarction risk and tamoxifen therapy for breast cancerTamoxifen therapy in breast cancer control worldwide.Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialTamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids.Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolitesPotential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.Update on cardiotoxicity of anti-cancer treatments.Principles of a risk evaluation and mitigation strategy (REMS) for breast cancer patients receiving potentially cardiotoxic adjuvant treatments.An overview of considerations for the testing of tamoxifen as a preventive for breast cancer.Hormone replacement therapy. Cardioprotective effect is genuine.Treatment of elderly patients with breast cancerProtective actions of tamoxifen and 4-hydroxytamoxifen against oxidative damage to human low-density lipoproteins: a mechanism accounting for the cardioprotective action of tamoxifen?How safe is tamoxifen?Side effects of adjuvant tamoxifen.Comparative analysis of oestrogen and raloxifene effects on the phospholipid composition of high density lipoproteins in healthy postmenopausal women.Coronary heart disease mortality and adjuvant tamoxifen therapy.Hormonal chemoprevention of cancer in women.Recent advances in understanding the molecular mechanisms of tamoxifen action.Management of Menopausal Symptoms in Breast Cancer Patients
P2860
Q24532213-1DF77F38-74ED-4B4C-AF01-61CCC373CBA1Q24685693-0C2DE5EA-3101-4D9D-896B-7B2F5E6A6140Q24803259-C0219D93-BE45-4860-A2AE-0A476660097EQ28367785-10E51D45-84EC-4B5D-8DA8-CA7DEFA05B1DQ28368257-F99DB30E-866F-4C55-A3B8-FAD3BA187792Q30423459-66C57D6D-4E17-4977-9A0B-E1D2AF09E596Q33644539-CCD30DA5-3024-4167-8A3C-A621133727E2Q33683302-4F599F03-43F9-438F-882D-CC49F383E04CQ33698446-FA1DF24D-5118-4709-9732-6D6EED574481Q33790182-424DB14F-BDF2-40B3-A6AB-496282F98B85Q34742590-8D59486F-6BF4-4B1E-9554-61EA093EE21CQ34774040-903C6CC0-8CDF-4701-9F28-4ECEC0A6535AQ35045916-D2DC981E-E8E0-4A3F-A24B-E5B516BED00EQ35473061-1933E1B4-E437-44A7-86C1-A0353BCB14C6Q35605724-EC66D74C-E4DF-410D-A39B-0397016D5B91Q35821539-B1B9E538-2E9D-43F0-B7F0-D198F669BCDFQ35822775-FEEAE1E1-C4B3-4A6D-80A5-221D8D282820Q36050932-C830C7D7-FAF4-4EA9-A462-24E7CBEB18CDQ36054383-397457F8-F807-44A7-A8B4-7366F47AD516Q36352053-4142311D-E79A-4C26-97C0-839007A7DC00Q36508458-118C3B14-E767-4269-8F44-7F856306FB07Q36616900-6EFB27C9-DB0F-4AAF-8D9C-902A9F1B1174Q36669816-8CB404FD-03BE-4018-A1B4-5128775E2B7AQ36680024-4D1B0922-4330-402C-85B6-28D88463F9BBQ36695459-B1D94A1D-E4D0-49E9-88C9-360BFF98D460Q37195375-CEFBBC25-BB73-4DF6-A7DD-77F53DD07DA2Q37221922-806F0E79-854E-4667-A8F4-4CCBF99050C5Q38686222-97CD28D4-46EE-4550-A911-C387D2C21CC9Q38786052-34B21A0D-8371-42F3-B6A5-1A29E8695B66Q40925446-A8759FD3-4442-4D85-B318-3D237BA810FCQ42588952-3DD73F98-1074-4D7E-AA11-FC98F055F01EQ42764040-5F2FE563-0378-4ADF-AF8C-20071EAE1EFEQ42809112-9B8531DD-57FC-4597-A9D5-C5A636894759Q43150387-A8FBE0F8-C6C5-414D-8BE3-93D851B19C83Q43161753-C9C7613A-35EB-455F-BA55-BD5E1792B6A1Q44693744-C1B55B49-6DE0-4C66-82C5-572F31884931Q44758234-92A04105-99E0-4CE9-86D0-A6250B64A128Q46728895-BDA568BB-AA48-4240-B188-D6BC99F6496AQ47785739-0B8E79FD-03D5-4F92-82D8-BFA9CB7A5ED0Q58136310-69003DE8-E176-4B90-B8AE-511105104FCD
P2860
Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@ast
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@en
type
label
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@ast
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@en
prefLabel
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@ast
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@en
P2860
P356
P1433
P1476
Fatal myocardial infarction in ...... ttish Breast Cancer Committee.
@en
P2093
McDonald CC
Stewart HJ
P2860
P304
P356
10.1136/BMJ.303.6800.435
P407
P577
1991-08-01T00:00:00Z